Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2024International Journal of Molecular SciencesOpen Access

(R)-(-)-Ketamine: The Promise of a Novel Treatment for Psychiatric and Neurological Disorders

View Full Paper
Ask AI
Bookmark
Share

Authors

HSHana ShafiqueDuke UniversityJDJulie DemersUniversity of IndianapolisJBJulia BiesiadaIndiana University – Purdue University Indianapolis

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shafique et al. (2024) studied this question.

synapsesocial.com/papers/68e63e25b6db6435875d00cbhttps://doi.org/10.3390/ijms25126804
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The neural basis underlying female vulnerability to depressive disorders2023 · 10 citations
  2. 2Arketamine, a new rapid-acting antidepressant: A historical review and future directions2022 · 90 citations
  3. 3Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine2021 · 215 citations